Dr. Ho is an associate professor of medicine in the Division of Hematology/Oncology, Department of Internal Medicine at Mayo Clinic, Phoenix, Arizona.
Recognizing hereditary syndromes in renal cell carcinoma
Patients may require specific diagnostic, surveillance, and therapeutic management.
How to choose systemic therapy for metastatic RCC
Combination therapy is the first-line standard for metastatic renal cell carcinoma.
Ultrasound imaging system now available to guide nonsurgical urology procedures
CPT 49186 vs 38780: Coding retroperitoneal mass excision
From BCG shortage to scientific surge: Inside the NMIBC treatment renaissance
CHAI biomarkers demonstrate prognostic utility for high-grade Ta NMIBC